Trial NCT02780700

View at ClinicalTrials.gov 
Org. Study IDs: 1199.251

Last trial update was posted on 2018-10-11

MeSH Interventions

Capecitabine Nintedanib

MeSH Conditions

Colorectal Neoplasms

Other Conditions


Stopping Reasons

Substance discontinued

Limitations And Caveats

Trial was terminated prematurely because it was determined that nintedanib monotherapy demonstrated lack of efficacy in this indication in pivotal Phase III trial (LUME-Colon 1) that was ongoing at the time of the initiation of this trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID